Nongyao Nonpanya
Datos Biográficos
| ID | 9996079 |
|---|---|
| NOMBRE | Nongyao Nonpanya |
| NOMBRES | Nongyao |
| APELLIDO | Nonpanya |
| FIRMA | NONPANYA N |
| AFILIACIONES | University of Alabama at Birmingham |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| OBRAS COMO AUTOR | 1 |
| OBRAS COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2023 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2023 |
| ÍNDICE H | 0 |
A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand
Background: variants (gBRCA) in high-risk breast cancer patients is known to be cost-effective in high-income countries. Nationwide adoption of genetics testing in high-risk breast cancer population remains poor. Our study aimed to assess gBRCA health economics data in the middle-income country setting of Thailand. Methods: Decision tree and Markov model were utilized to assess cost-utility between the testing vs. no-testing groups from a societa…
Sin obras prominentes en esta página.
A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand
Background: variants (gBRCA) in high-risk breast cancer patients is known to be cost-effective in high-income countries. Nationwide adoption of genetics testing in high-risk breast cancer population remains poor. Our study aimed to assess gBRCA health economics data in the middle-income country setting of Thailand. Methods: Decision tree and Markov model were utilized to assess cost-utility between the testing vs. no-testing groups from a societa…
BRCA gene mutations in cancer (1 obra) · Breast cancer (1 obra) · Cancer (1 obra) · Cost effectiveness (1 obra) · Environmental health (1 obra) · Genetic testing (1 obra) · Genomics and Rare Diseases (1 obra) · Health Systems, Economic Evaluations, Quality of Life (1 obra) · Internal Medicine (1 obra) · Medicine (1 obra)